Search

everythinglearnresearchcommunity

for

Search:↓

Recognizing the different stages of alopecia areata is crucial for accurate diagnosis and treatment.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

Women with premature ovarian insufficiency have a worse cardiovascular risk profile than premenopausal women.

Blocking IL-17 signaling can delay skin aging and improve skin and hair health.

Linalool in personal care products may worsen frontal fibrosing alopecia by damaging hair follicle stem cells and triggering harmful immune responses.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

Cyclosporin is effective in treating dog skin diseases and has fewer side effects compared to other treatments.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Androgenic steroids can slow down or stop the growth of certain skin fungi.

Monitoring steroid hormones in blood can better detect testosterone doping.

Occipital scalp affects female hair loss; terminal/vellus ratio helps diagnose androgenetic alopecia.

A rare genetic mutation found in an Indian family can be detected through prenatal screening.

Nitrogen mustard was not very effective for hair regrowth in alopecia areata and has potential skin cancer risk.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

ILC1 cells contribute to hair loss in alopecia areata.

The conclusion is that a new method could improve the identification of autoimmune targets in alopecia areata, despite some limitations.

Nitric oxide is important for skin functions and both helps protect against and contributes to skin inflammation and sensitization.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

New treatments for child hair loss due to immune issues are effective but not yet officially approved.

Older mice healed wounds better but lost more weight and might have weaker immune systems afterward.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

SM04755 may be an effective topical treatment for psoriasis.

The conference concluded that understanding hair and nail disorders is important, iron deficiency may be linked to hair loss, and while some treatments for skin conditions are effective, they may have risks and high costs.

Targeting mTOR in myeloid cells may help reduce psoriasis symptoms.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

AGA is a common hair loss affecting both genders, treated with various therapies to promote regrowth and slow thinning.